GlassScriptPhysician profile
Tracy Ann Ruegg
NPI 1235343914
$1,315.70
in general payments reported to CMS, 2019-2025
9 companies · $316 in 2025
The $316 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $107 · 2023: $535 · 2024: $358 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,129 · Education: $80.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,128.60 |
| Education | $80.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $306.93 | 2023-2024 | Opdivo, Onureg |
| Astrazeneca Pharmaceuticals LP | $232.48 | 2023 | Lynparza |
| Janssen Biotech, INC. | $150.00 | 2025 | Carvykti, Rybrevant |
| Gilead Sciences, INC. | $125.00 | 2024 | Trodelvy |
| Glaxosmithkline, LLC. | $119.41 | 2023 | Ojjaara |
| Seagen INC. | $109.15 | 2023 | Tukysa |
| Karyopharm Therapeutics INC. | $107.10 | 2022 | |
| Springworks Therapeutics, INC. | $85.63 | 2025 | Gomekli |
| Astellas Pharma US INC | $80.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Ruegg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.